CERS is Cerus Corporation (Healthcare) — a non-dividend-paying stock. Trading at $2.59. Market cap: $522M. Capital Quality Rank: 50/100 — Stagnant mediocrity.
Stock snapshot
| Price | $2.59 |
| Market cap | $522M |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 50 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -8.0% |
| Revenue CAGR (3y) | 7.5% |
| Shareholder buyback yield | -3.16% |
| Altman Z-score zone | Distress |
About CERS
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
Related non-dividend companies
Other non-dividend stocks investors research alongside CERS. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is CERS's current stock price?
CERS (Cerus Corporation) is currently trading at $2.59.
Does CERS pay a dividend?
CERS (Cerus Corporation) does not currently pay a regular dividend.
What is CERS's Capital Quality Rank?
CERS has a Capital Quality Rank of 50/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track CERS in DiviDrip
Add CERS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search CERS and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.